Archives
-
Gamma-Linolenic Acid: Assay Workflows & Uses
2026-08-25
Gamma-linolenic acid (GLA) combines LTB4-pathway modulation with practical utility in inflammation, lipid signaling, cytotoxicity, and translational disease models. This guide turns its quantitative profile into executable assay workflows, controls, and troubleshooting decisions while clearly separating established findings from method-development suggestions.
-
HIV-1 Protease Autoprocessing in High-Throughput Screening
2026-08-25
The reference study developed and validated a cell-based AlphaLISA platform that measures HIV-1 protease precursor autoprocessing rather than only mature-enzyme activity. Its selective response to known inhibitors and resistance-associated mutations makes the assay useful for mechanistic drug discovery, compound triage, and assessment of protease inhibitor resistance.
-
DiscoveryProbe Protease Inhibitor Library Workflow
2026-08-24
Build more informative protease screens by combining an 825-compound, pre-dissolved inhibitor collection with biochemical confirmation and high-content phenotyping. This workflow translates mechanistic lessons from a recent DNA-defense study into practical controls for protease inhibition, apoptosis assay design, cancer research, and infectious disease research.
-
IEM 1460 in Excitotoxicity Assays
2026-08-24
This scenario-driven guide explains how IEM 1460 (SKU B6811) can support selective AMPA receptor inhibition, excitotoxicity research, and neuroprotection experiments. It covers assay controls, DMSO handling, storage, interpretation, and practical vendor-selection criteria without overstating evidence from related compounds.
-
HyperScribe T7 High Yield Cy5 RNA Labeling Kit Guide
2026-08-23
Build sensitive fluorescent RNA probes for in situ hybridization, Northern blot hybridization, and RNA–protein condensation studies with tunable Cy5-UTP incorporation. This workflow-focused guide shows how to balance probe yield, fluorescence, hybridization performance, and assay-specific controls.
-
Protease Inhibitors and Light-Induced Stomatal Opening
2026-08-22
Wang et al. used chemical screening to identify protease inhibitors that suppress blue light-induced stomatal opening in Commelina benghalensis. Their results connect several inhibitor treatments to reduced plasma membrane H+-ATPase phosphorylation while leaving phototropin activity and ABA-dependent responses largely unaffected, providing chemical probes for unresolved guard-cell signaling steps.
-
Antiseptics for Burns: Evidence from a Cochrane Review
2026-08-22
The 2017 Cochrane review examined whether topical antiseptics improve healing, prevent infection, or cause harm in people with burns. Its main contribution was a structured comparison of diverse topical strategies and clinically relevant outcomes, while highlighting uncertainty caused by heterogeneous interventions, comparators, and follow-up periods.
-
HyperScribe T7 Cy5 RNA Labeling Kit Guide
2026-08-21
The HyperScribe T7 High Yield Cy5 RNA Labeling Kit is a tunable Cy5 RNA labeling kit for producing fluorescent RNA probes by T7 in vitro transcription. Its Cy5-UTP substitution can be adjusted to balance transcript yield and labeling efficiency, while the referenced lipid-nanoparticle study provides biological context for mRNA detection without validating this kit for therapeutic delivery.
-
ROS-Responsive LNPs for Tumor-Selective mRNA Delivery
2026-08-20
Cai and colleagues developed a combinatorial library of thioketal-containing, ROS-degradable lipids and identified BAmP-TK-12 as a lipid nanoparticle component that preferentially delivers mRNA to tumor cells. Delivery of mRNA encoding the RAS-cleaving bacterial protease DUF5 depleted mutant RAS and produced stronger antitumor activity than a small-molecule RAS inhibitor in the reported models.
-
Nonselective β-Blockade and HCT Engraftment
2026-08-20
The reference study shows that nonselective β-adrenergic receptor inhibitors can delay hematopoietic regeneration after allogeneic hematopoietic cell transplantation, whereas β1-selective inhibition did not produce the same effect in the tested mouse and human settings. Its cross-species comparison links transplant pharmacology with peripheral nerve–stromal signaling and identifies treatment context, graft type, and transplanted cell dose as important variables for interpretation.
-
AS1842856: A Causal Foxo1 Assay Tool
2026-08-19
AS1842856 is a selective Foxo1 inhibitor for dissecting transcriptional control of gluconeogenesis, autophagy, and MSC state. This article presents an assay-centered framework for connecting Foxo1 activity with the iron-dependent KDM4D–PI3K–Akt pathway while avoiding overinterpretation.
-
WZ4003: NUAK1/2 Inhibitor Workflows
2026-08-19
WZ4003 is a selective NUAK1/2 inhibitor for connecting kinase signaling with cell migration, proliferation, invasion, and tau biology. This practical guide translates its target-validation data into reproducible cell-based and brain-slice workflows, with controls and troubleshooting strategies for interpreting pathway-specific effects.
-
Praeruptorin A Targets ERK/MMP1 in HCC Metastasis
2026-08-18
The reference study identifies an antimetastatic action of praeruptorin A in human hepatocellular carcinoma cells that is separable from general cytotoxicity. Its combination of migration and invasion assays with ERK silencing supports an ERK/MMP1 signaling mechanism, while also defining important limits for translating an in vitro finding into liver cancer therapy.
-
LY2886721: Practical BACE1 Inhibition Workflows
2026-08-17
LY2886721 enables controlled BACE1 enzyme inhibition across cellular, neuronal, biomarker, and in vivo Alzheimer’s disease research workflows. This guide emphasizes exposure calibration, amyloid beta reduction, synaptic-function controls, and solubility-aware handling rather than treating maximal inhibition as the sole endpoint.
-
WST-8 Glucose Uptake Assay: Ion-Aware Design
2026-08-17
Learn how the WST-8 Glucose Uptake Assay Kit converts 2-deoxyglucose processing into a quantitative, non-radioactive readout. This guide adds an ion-aware framework for interpreting glucose uptake after peptide-mediated nucleic acid delivery.